Page 4,521«..1020..4,5204,5214,5224,523..4,5304,540..»

Bipolar Disorder Stem Cell Study Opens Doors To Potential New Treatments

Posted: Published on March 27th, 2014

Image Caption: These colorful neurons, seen forming connections to one another across synapses, were grown from induced pluripotent stem cells -- ones that were derived from skin cells taken from people with bipolar disorder. New research shows they act, and react to the bipolar drug lithium, differently from neurons derived from people without bipolar disorder. Credit: University of Michigan Pluripotent Stem Cell Research Lab [ Watch the Video: First Stem Cell Study of Bipolar Disorder Yields Promising Results ] April Flowers for redOrbit.com Your Universe Online Bipolar disorder affects 200 million people globally, and yet there are so many questions surrounding the condition. Why are individuals with bipolar disorder prone to manic highs and deep, depressed lows? If there is no single gene to blame, why does bipolar disorder run so strongly in families? And why, with the enormous number of people suffering from bipolar disorder, is it so hard to find new treatments? A new study from the University of Michigan Medical School, funded by the Heinz C. Prechter Bipolar Research Fund, reveals that the answers might actually be found within our stem cells. To derive the first-ever stem cell lines specific to bipolar disorder, the research team used … Continue reading

Posted in Cell Medicine | Comments Off on Bipolar Disorder Stem Cell Study Opens Doors To Potential New Treatments

Spark And Genable Tech Collaborate On Rare Gene Therapy

Posted: Published on March 27th, 2014

By Estel Grace Masangkay Spark Therapeutics and Genable Technologies announced that they have signed a collaboration agreement to develop GT038, Genables lead therapeutic drug for the treatment of rhodopsin-linked autosomal dominant retinitis pigmentosa (RHO adRP). The partnership will allow Genable to license specific adeno-associated virus (AAV) vector manufacturing patents from Spark. Spark will gain exclusive manufacturing rights of the product and will receive milestone payments and royalty on future sales of GT038. The company is also eligible to receive near term revenue from the manufacture and supply of GT038, for which it will provide development advice and expertise. Jeffrey Marrazzo, Spark Therapeutics co-founder, president and CEO, said, We are excited to apply our deep expertise in AAV clinical development and manufacturing to augment Genable's great work, and expand the number of debilitating diseases of the eye that can be addressed through gene therapy. GT038 is a potential drug for the treatment of rhodopsin (RHO)-linked autosomal dominant retinitis pigmentosa (adRP), which affects approximately 30,000 patients around the world. The disease is an inherited retinal dystrophy that often leads to blindness. No approved pharmacologic treatment for adRP currently exists. GT038 has an established safety and efficacy profile for the utilization of AAV … Continue reading

Posted in Retinitis Pigmentosa | Comments Off on Spark And Genable Tech Collaborate On Rare Gene Therapy

Stem cell transplant (myeloma by Tarsam Chand) – Video

Posted: Published on March 27th, 2014

Stem cell transplant (myeloma by Tarsam Chand) By: CancerStories … Continue reading

Posted in Stem Cell Transplant | Comments Off on Stem cell transplant (myeloma by Tarsam Chand) – Video

The Medical Marketing Group of Beverly Hills Congratulates Plastic Surgeon Dr. Banthia on Revolutionary Laser Neck …

Posted: Published on March 27th, 2014

Beverly Hills, CA (PRWEB) March 27, 2014 It is the belief of The Medical Marketing Group of Beverly Hills (TMMG) that online marketing should be affordable and customizable to suit their needs and the needs of their practice. By offering an exclusive web marketing platform through a tiered system that allows doctors to choose the services they desire, any medical professional can achieve affordable marketing services than help grow their medical practice according to their unique needs, preferences, and goals. TMMG has been able to provide these very services to Dr. Vish Banthia, who is excited to provide a revolutionary laser neck procedure. Dr. Vish Banthia is the primary physician of Beverly Hills Facial Plastic Surgery and Aesthetic Center whose primary goal is achieving a rejuvenated, refreshed, and natural look for his patients. Dr. Banthia holds board certifications from the American Board of Facial Plastic and Reconstructive Surgery and the American Board of Otolaryngology-Head and Neck Surgery, and has performed thousands of facelift procedures. As an expert in both minimally invasive and comprehensive facial rejuvenation, Dr. Banthia has lectured on his techniques in minimally invasive surgery and laser surgery to plastic surgeons, facial plastic surgeons, and dermatologists. He is proud … Continue reading

Posted in Aesthetic Surgery | Comments Off on The Medical Marketing Group of Beverly Hills Congratulates Plastic Surgeon Dr. Banthia on Revolutionary Laser Neck …

Pioneers in Adult Stem Cell Therapy Honored

Posted: Published on March 27th, 2014

The Alliance for the Advancement of Adult Stem Cell Therapy and Research hosted an awards luncheon for doctors and patients from around the world to recognize and honor their outstanding contributions and achievements in adult stem cell therapy. The Stem Cell Alliance event celebrated the revolutionary strides in the field of adult stem cell treatments for cardiac, pulmonary, neurological, spinal cord injuries and vascular diseases. The Stem Cell Alliance event celebrated the revolutionary strides in the field of adult stem cell treatments for cardiac, pulmonary, neurological, spinal cord injuries and vascular diseases. Kelly Drouin of the Stem Cell Alliance, conferred awards to the Regenocyte medical team including Doctors Zannos Grekos, Hector Rosario, Eduardo Mejia and, in absentia, Victor Matos for their work and dedication in adult stem cell research and treatment. These doctors are pioneers in clinical application of adult stem cell therapy and heroes to the many patients in attendance. Some of the patients had lost all hope after being told by their own doctors that they were out of options in the treatment of their disease, said Drouin. The Stem Cell Alliance also recognized and awarded each of the attending patients for their courage and for leading the … Continue reading

Comments Off on Pioneers in Adult Stem Cell Therapy Honored

Teen uses optimism as medicine; works for muscular dystrophy cure

Posted: Published on March 27th, 2014

By Stacy Jacobson sjacobson@abcnews4.com MOUNT PLEASANT, S.C. (WCIV) -- For Caleb Sizemore, 16, some loads are a struggle. Caleb was diagnosed with Duchenne muscular dystrophy when he was 7. "Sometimes it's just coming to the realization that you won't live as long. But you just have to make the best of what you've got," he said. "He loses his muscle strength over time. It makes him weaker than most kids. Makes him, he has to take a battery of medicines," Caleb's father Richard Sizemore said. The Academic Magnet junior is on the school crew team, but he's also part of Caleb's Cure Team. "It's important to raise [money] because it goes to research for people who have Duchenne muscular dystrophy. I have a mild form of it, but a lot of people have a lot worse symptoms and they need to be cured," Caleb said. It's a grown-up outlook for a boy who's had to grow up faster than most. He's raising money for the Muscular Dystrophy Association to find a treatment, or even a cure. "I've learned a great deal from Caleb. Caleb's one of my heroes," his father said. "It makes me feel honored and it makes me … Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Teen uses optimism as medicine; works for muscular dystrophy cure

History Is Made with First Small LVAD Implant for Young Muscular Dystrophy Patient

Posted: Published on March 27th, 2014

Contact Information Available for logged-in reporters only Newswise DALLAS March 26, 2014 Today, were going to make history, said 18-year-old Eric Ramos on the day UTSouthwestern Medical Center doctors operated on his ailing heart. Eric, who has Duchenne muscular dystrophy, is one of only three patients in the United States with the condition to receive a battery-operated left ventricular assist device (LVAD) to keep his weakening heart pumping blood through his body. He is the first patient in the country to be given a specific, smaller LVAD, which means doctors would not need to manipulate his diaphragm, which could compromise his already limited pulmonary function. Duchenne muscular dystrophy, a recessive X-linked form of the disease, affects around 1 in 3,600 boys. Diagnosed at age 6, Eric has used a wheelchair for the past seven years because his muscles, including his heart and lungs, are rapidly degenerating. Nevertheless, Eric has the heart of a champion. He views his latest challenge as an unreal accomplishment and says he is honored to be part of history, paving the way for other Duchenne patients with advanced heart failure. Lead surgeon Dr. Dan Meyer, Professor of Cardio Thoracic Surgery and Director of Mechanical Assist Devices, … Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on History Is Made with First Small LVAD Implant for Young Muscular Dystrophy Patient

Bank to Bedside: A Fathers Journey to Become a Catalyst for Change

Posted: Published on March 27th, 2014

When it comes to matters of the heart, people often respond with a gut reaction rather than a well-thought-out plan of action. When Ilan Ganot, a banker at JPMorgan Chase (JPM) learned his two-year-old son was diagnosed with Duchenne Muscular Dystrophy, a rare form of the disease, his world stopped. It was the worst thing in the world. In my life. No question, Ganot said. With no real background in medicine, but a heart full of hope, Ganot vowed to stop at nothing to help his son live. - Ilan Ganot A reaction from the heart, yes. But one also driven by intense dedication and well-planned determination to succeed. From Bank to Bedside Ganots son, Eytani, was born a healthy, happy baby boy. But a few months into his life, Ganot and his wife Annie began to notice differences from other children. (He showed) delays compared to his age group, Ganot said. Usually kids crawl at six months, he crawled at a year. Usually kids walk at a year, he didnt walk until about 18 months. Once the realization set in, Eytani went through a series of evaluations, and the diagnosis at the end was low tone, meaning the young … Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Bank to Bedside: A Fathers Journey to Become a Catalyst for Change

Health Headlines: Liquid Nicotine, New Epilepsy Treatment, Nasal Filter – Video

Posted: Published on March 27th, 2014

Health Headlines: Liquid Nicotine, New Epilepsy Treatment, Nasal Filter Dr. Adam Ofer gives us some insight into today's health headlines. Some of the topics in include new hope for epileptics, scientists testing a new way to red... By: CBS New York … Continue reading

Comments Off on Health Headlines: Liquid Nicotine, New Epilepsy Treatment, Nasal Filter – Video

Pediatric Epilepsy Treatment Reduces Seizures – Video

Posted: Published on March 27th, 2014

Pediatric Epilepsy Treatment Reduces Seizures A Long Journey Has a Happy Ending Find this story and more in our 2013 Alexian Brothers Health System Annual Review at http://www.AlexianBrothersHealth.org/Annual-R... By: AlexianBrothersHlth … Continue reading

Comments Off on Pediatric Epilepsy Treatment Reduces Seizures – Video

Page 4,521«..1020..4,5204,5214,5224,523..4,5304,540..»